GastroAGI Logo
OverviewBlogsAbout
Trending TopicsDaily BriefConference
Topics/Small and Large Bowel/The Fiesole Consensus report
40

The Fiesole Consensus report

Clinical knowledge base written and curated by GastroAGI Team from primary medical literatureLast updated January 1, 2026

The Fiesole Consensus Report refers to an international set of guidelines and recommendations on the diagnosis, management, and prevention of diverticular disease. This consensus was developed by a group of 32 experts from 14 countries, employing a structured Delphi process that adheres to the PICO (Population, Intervention, Comparison, Outcome) framework and GRADE (Grading of Recommendations, Assessment, Development, and Evaluation) methodology. The report is designed to standardize care and provide evidence-based guidance for clinicians dealing with this increasingly prevalent condition.

Key Highlights of the Fiesole Consensus Report:

1. Definitions and Epidemiology

  • Diverticulosis: The presence of colonic diverticula (small pouches in the colon wall) without associated symptoms.
  • Diverticular disease: When diverticula are associated with symptoms or complications such as inflammation or infection.
  • Diverticulosis is the most common structural abnormality of the colon in developed countries, with an increasing prevalence worldwide.
  • Approximately 20–25% of individuals with diverticulosis develop symptoms that fall under diverticular disease.

2. Risk Factors

  • High dietary fiber intake is protective against diverticular disease.
  • Risk factors include:
  • Smoking
  • Obesity
  • Use of certain medications such as non-steroidal anti-inflammatory drugs (NSAIDs), corticosteroids, opioids, and immunotherapy agents.

3. Diagnosis

  • Imaging is critical for diagnosing suspected acute diverticulitis.
  • Ultrasound: May be appropriate when performed by experienced clinicians.
  • CT Scans: Preferred for diagnosing complicated cases of diverticulitis.
  • Diverticulosis itself does not require any specific treatment or imaging unless symptoms or complications arise.

4. Management of Diverticular Disease

  • Symptomatic Uncomplicated Diverticular Disease (SUDD):
  • Dietary fiber, selected probiotics, mesalazine, and rifaximin may help alleviate symptoms.
  • Acute Uncomplicated Diverticulitis:
  • Routine antibiotic use is not recommended.
  • Complicated Diverticulitis:
  • Imaging is essential to guide management.
  • Elective Surgery:
  • Should be individualized based on the patient's quality of life rather than the number of episodes of diverticulitis.

5. Surgical Management

  • Surgery is reserved for cases where complications arise or when symptoms significantly impair quality of life.
  • Decisions should prioritize the patient's preferences and overall well-being.

6. Research Priorities

  • The report emphasizes the need for further research into:
  • Microbiome characterization in diverticular disease.
  • Genetic risk profiling to better understand individual susceptibility.
  • Long-term outcomes of selective antimicrobial and surgical strategies.

Conclusion

The Fiesole Consensus Report aims to provide a comprehensive and standardized approach to the diagnosis, treatment, and prevention of diverticular disease. By integrating the latest evidence and expert opinions, the report seeks to optimize patient outcomes across diverse healthcare systems. It also identifies critical gaps in knowledge and highlights areas for future research, ensuring that the management of diverticular disease continues to evolve in alignment with emerging scientific insights.

Related Q&A

41

Rome III vs Rome IV Criteria for IBS Diagnosis in Southeast Asia - J of JGH - Jan,26

The study published in the Journal of Gastroenterology and Hepatology (JGH) on January 26, titled "Rome III vs Rome IV Criteria for IBS Diagnosis in Southeast Asia," investigates...

42

Advances in Gut Microbiome and Metabolomics in IBD–Depression Comorbidity - J of JGH Jan,26

As of my training cutoff in October 2023, I cannot access or summarize the specific contents of the "Journal of Gastroenterology and Hepatology (JGH)" article dated January 26....

43

Prevention of Acute Diverticulitis and DICA Score -Eur.J.Gastroenterol.Hepatol Jan 26

The prevention of acute diverticulitis (AD) based on the DICA (Diverticular Inflammation and Complication Assessment) score offers several key insights and takeaways for individualized management strategies. Below is...

44

A Gut Feeling

"A Gut Feeling" refers to the intuitive understanding of the profound impact the gut microbiota has on overall health, including gastrointestinal (GI), immune, endocrine, metabolic, and even neurological...

45

Long-Term Venous Thromboembolism Risk in Microscopic Colitis

The long-term risk of venous thromboembolism (VTE) in individuals with microscopic colitis (MC) has been evaluated in a nationwide Swedish cohort study. Microscopic colitis is an inflammatory bowel...

46

Efficacy and Safety of Linaclotide vs Plecanatide for Chronic Idiopathic Constipation

Linaclotide and plecanatide are both guanylate cyclase-C (GC-C) agonists approved for the treatment of chronic idiopathic constipation (CIC) in adults. While both drugs share a similar mechanism of...

GastroAGI Logo

We are pioneers in clinical intelligence, dedicated to helping gastroenterologists harness the power of artificial intelligence to drive precision, efficiency, and patient growth.

For You

For StudentsFor CliniciansFor ResearchersSoonFor Patients

Core Tools

MELD-Na ScoreChild-PughFIB-4 IndexGlasgow-BlatchfordBISAP Score

Explore

OverviewAboutCalculators
Trending Topics
Conference Briefings
Blog Insights
©GastroAGI 2026
Privacy PolicyTerms of UseMedical Disclaimer